ABSTRACT
Sleep disturbances are common in neurodegenerative diseases. Disturbed sleep can result
in fatigue, irritability, morning headaches, impaired motor and cognitive skills,
depression, and daytime somnolence. The major sleep complaints include insomnia, hypersomnia,
parasomnia, excessive nocturnal motor activity, circadian sleep–wake rhythm disturbance,
and respiratory dysrhythmia. The pathogenetic mechanisms of sleep disturbances may
be secondary to direct structural alteration of the sleep–wake generating neurons
or from several other indirect mechanisms. At the biochemical level, neurodegenerative
diseases may be largely classified as tauopathies, α-synucleinopathies, and other
diseases. Overnight polysomnography (PSG), Multiple Sleep Latency Test, Maintenance
of Wakefulness Test, and actigraphy are some important diagnostic laboratory tests
in the evaluation of sleep disturbances. Management of sleep disturbances is complex
and is based primarily on the nature of the sleep disturbance. The clinical profiles,
pathogenetic mechanisms, PSG findings, and management issues are discussed here with
reference to some common neurodegenerative diseases.
KEYWORDS
Neurodegenerative disease - sleep disturbance - polysomnography (PSG) - molecular
neurobiology
REFERENCES
1
Degenerative diseases of the nervous system . In: Ropper AH, Brown RH Adams and Victor's Principles of Neurology 8th ed. New York;
McGraw Hill 2006: 1108
2
The Huntington's Disease Collaborative Research Group .
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's
disease chromosomes.
Cell.
1993;
72(6)
971-983
3
Polymeropoulos M H, Higgins J J, Golbe L I et al..
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23.
Science.
1996;
274(5290)
1197-1199
4 Conner K E, Rosenberg R N.
The genetic basis of ataxia . In: Rosenberg RN, Prusiner SV, Di Mauro S, Barcha RS The Molecular and Genetic Basis
of Neurological Disease. Boston; Butterworth-Heinemann 1997: 503-544
5
Boeve B F, Silber M H, Parisi J E et al..
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.
Neurology.
2003;
61(1)
40-45
6
Schenck C H, Mahowald M W.
A polysomnographic, neurologic, psychiatric and clinical outcome report on 70 consecutive
cases with REM sleep behavior disorder (RBD): Sustained clonazepam efficacy in 89.5%
of 57 treated patients.
Cleve Clin J Med.
1990;
57(Suppl)
10-24
7 Katzman R, Terry R. The Neurology of Aging. Philadelphia; Davis 1983
8
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E M.
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under
the auspices of Department of Health and Human Services Task Force on Alzheimer's
Disease.
Neurology.
1984;
34(7)
939-944
9
Vitiello M V, Prinz P N.
Alzheimer's disease. Sleep and sleep/wake patterns.
Clin Geriatr Med.
1989;
5(2)
289-299
10
Moe K E, Vitiello M V, Larsen L H, Prinz P N.
Symposium: cognitive processes and sleep disturbances: sleep/wake patterns in Alzheimer's
disease: relationships with cognition and function.
J Sleep Res.
1995;
4(1)
15-20
11
Hoch C C, Reynolds III C F, Kupfer D J, Houck P R, Berman S R, Stack J A.
Sleep-disordered breathing in normal and pathologic aging.
J Clin Psychiatry.
1986;
47(10)
499-503
12
Erkinjuntti T, Partinen M, Sulkava R, Telakivi T, Salmi T, Tilvis R.
Sleep apnea in multiinfarct dementia and Alzheimer's disease.
Sleep.
1987;
10(5)
419-425
13
Loewenstein R J, Weingartner H, Gillin J C, Kaye W, Ebert M, Mendelson W B.
Disturbances of sleep and cognitive functioning in patients with dementia.
Neurobiol Aging.
1982;
3(4)
371-377
14
Reynolds III C F, Kupfer D J, Houck P R et al..
Reliable discrimination of elderly depressed and demented patients by electroencephalographic
sleep data.
Arch Gen Psychiatry.
1988;
45(3)
258-264
15
Allen S R, Seiler W O, Stähelin H B, Spiegel R.
Seventy-two hour polygraphic and behavioral recordings of wakefulness and sleep in
a hospital geriatric unit: comparison between demented and nondemented patients.
Sleep.
1987;
10(2)
143-159
16
Feinberg I, Koresko R L, Heller N.
EEG sleep patterns as a function of normal and pathological aging in man.
J Psychiatr Res.
1967;
5(2)
107-144
17
Prinz P N, Peskind E R, Vitaliano P P et al..
Changes in the sleep and waking EEGs of nondemented and demented elderly subjects.
J Am Geriatr Soc.
1982;
30(2)
86-93
18
Montplaisir J, Petit D, Lorrain D, Gauthier S, Nielsen T.
Sleep in Alzheimer's disease: further considerations on the role of brainstem and
forebrain cholinergic populations in sleep-wake mechanisms.
Sleep.
1995;
18(3)
145-148
19
Benca R M, Obermeyer W H, Thisted R A, Gillin J C.
Sleep and psychiatric disorders. A meta-analysis.
Arch Gen Psychiatry.
1992;
49(8)
651-668
discussion 669-670
20 Bliwise D L.
Dementia . In: Kryger MH, Roth T, Dement WC Principles and Practice of Sleep Medicine. Philadelphia;
Saunders 1994: 790
21
Vitiello M V, Prinz P N, Williams D E, Frommlet M S, Ries R K.
Sleep disturbances in patients with mild-stage Alzheimer's disease.
J Gerontol.
1990;
45(4)
M131-M138
22
Prinz P N, Peskind E R, Vitaliano P P et al..
Changes in the sleep and waking EEGs of nondemented and demented elderly subjects.
J Am Geriatr Soc.
1982;
30(2)
86-93
23
Bliwise D L, Tinklenberg J, Yesavage J A et al..
REM latency in Alzheimer's disease.
Biol Psychiatry.
1989;
25(3)
320-328
24
Yesavage J A, Taylor J L, Kraemer H, Noda A, Friedman L, Tinklenberg J R.
Sleep/wake cycle disturbance in Alzheimer's disease: how much is due to an inherent
trait?.
Int Psychogeriatr.
2002;
14(1)
73-81
25
Onen F, Onen S H.
[Sleep rhythm disturbances in Alzheimer's disease].
Rev Med Interne.
2003;
24(3)
165-171
26
Crowley K, Sullivan E V, Adalsteinsson E, Pfefferbaum A, Colrain I M.
Differentiating pathologic delta from healthy physiologic delta in patients with Alzheimer
disease.
Sleep.
2005;
28(7)
865-870
27
Boddy F, Rowan E N, Lett D, O'Brien J T, McKeith I G, Burn D J.
Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's
disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease.
Int J Geriatr Psychiatry.
2007;
22(6)
529-535
28
Park M, Comella C L, Leurgans S E, Fan W, Wilson R S, Bennett D A.
Association of daytime napping and Parkinsonian signs in Alzheimer's disease.
Sleep Med.
2006;
7(8)
614-618
29
Taylor J L, Friedman L, Sheikh J, Yesavage J A.
Assessment and management of “Sundowning” phenomena.
Semin Clin Neuropsychiatry.
1997;
2(2)
113-122
30
Vitiello M V, Bliwise D L, Prinz P N.
Sleep in Alzheimer's disease and the sundown syndrome.
Neurology.
1992;
42(7, Suppl 6)
83-93
discussion 93-94
31
Wu Y H, Swaab D F.
Disturbance and strategies for reactivation of the circadian rhythm system in aging
and Alzheimer's disease.
Sleep Med.
2007;
8(6)
623-636
32
Wu Y H, Swaab D F.
The human pineal gland and melatonin in aging and Alzheimer's disease.
J Pineal Res.
2005;
38(3)
145-152
33 Chokroverty S.
Sleep, breathing, and neurologic disorders . In: Chokroverty S Sleep Disorders Medicine: Basic Science, Technical Considerations,
and Clinical Aspects. 3rd ed. Philadelphia; Elsevier/Butterworth 2009
34
Bliwise D L.
Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting?.
J Psychosom Res.
2002;
53(1)
539-546
35
Grace J B, Walker M P, McKeith I G.
A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's
disease.
Int J Geriatr Psychiatry.
2000;
15(11)
1028-1033
36
Bahro M, Riemann D, Stadtmüller G, Berger M, Gattaz W F.
REM sleep parameters in the discrimination of probable Alzheimer's disease from old-age
depression.
Biol Psychiatry.
1993;
34(7)
482-486
37
Dykierek P, Stadtmüller G, Schramm P et al..
The value of REM sleep parameters in differentiating Alzheimer's disease from old-age
depression and normal aging.
J Psychiatr Res.
1998;
32(1)
1-9
38
Sinforiani E, Terzaghi M, Pasotti C, Zucchella C, Zambrelli E, Manni R.
Hallucinations and sleep-wake cycle in Alzheimer's disease: a questionnaire-based
study in 218 patients.
Neurol Sci.
2007;
28(2)
96-99
39
Gagnon J F, Petit D, Fantini M L et al..
REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease.
Sleep.
2006;
29(10)
1321-1325
40
Bonanni E, Maestri M, Tognoni G et al..
Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with
cognitive impairment.
J Sleep Res.
2005;
14(3)
311-317
41
Park M, Comella C L, Leurgans S E, Fan W, Wilson R S, Bennett D A.
Association of daytime napping and Parkinsonian signs in Alzheimer's disease.
Sleep Med.
2006;
7(8)
614-618
42
Rajput A, Rajput A H.
Progressive supranuclear palsy: clinical features, pathophysiology and management.
Drugs Aging.
2001;
18(12)
913-925
43
Aldrich M S, Foster N L, White R F, Bluemlein L, Prokopowicz G.
Sleep abnormalities in progressive supranuclear palsy.
Ann Neurol.
1989;
25(6)
577-581
44
Chokroverty S.
Sleep and degenerative neurologic disorders.
Neurol Clin.
1996;
14(4)
807-826
45
Perret J L, Jouvet M.
[Sleep study of progressive supranuclear paralysis].
Electroencephalogr Clin Neurophysiol.
1980;
49(3-4)
323-329
46
De Bruin V S, Machado C, Howard R S, Hirsch N P, Lees A J.
Nocturnal and respiratory disturbances in Steele-Richardson-Olszewski syndrome (progressive
supranuclear palsy).
Postgrad Med J.
1996;
72(847)
293-296
47
Arnulf I, Merino-Andreu M, Bloch F et al..
REM sleep behavior disorder and REM sleep without atonia in patients with progressive
supranuclear palsy.
Sleep.
2005;
28(3)
349-354
48
Sixel-Döring F, Schweitzer M, Mollenhauer B, Trenkwalder C.
Polysomnographic findings, video-based sleep analysis and sleep perception in progressive
supranuclear palsy.
Sleep Med.
2009;
10(4)
407-415
49
Pareja J A, Caminero A B, Masa J F, Dobato J L.
A first case of progressive supranuclear palsy and pre-clinical REM sleep behavior
disorder presenting as inhibition of speech during wakefulness and somniloquy with
phasic muscle twitching during REM sleep.
Neurologia.
1996;
11(8)
304-306
50
Massetani R, Arena R, Bonuccelli U, Salerno P, Muratorio A.
[Sleep in progressive supranuclear palsy].
Riv Patol Nerv Ment.
1982;
103(5)
215-224
51
Perret J L, Jouvet M.
[Sleep study of progressive supranuclear paralysis].
Electroencephalogr Clin Neurophysiol.
1980;
49(3-4)
323-329
52
Laffont F, Leger J M, Penicaud A et al..
[Sleep abnormalities and evoked potentials (VEP-BAER-SEP) in progressive supranuclear
palsy].
Neurophysiol Clin.
1988;
18(3)
255-269
53
Montplaisir J, Petit D, Décary A et al..
Sleep and quantitative EEG in patients with progressive supranuclear palsy.
Neurology.
1997;
49(4)
999-1003
54
Yasui K, Inoue Y, Kanbayashi T, Nomura T, Kusumi M, Nakashima K.
CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear
palsy and corticobasal degeneration.
J Neurol Sci.
2006;
250(1-2)
120-123
55
Stover N P, Watts R L.
Corticobasal degeneration.
Semin Neurol.
2001;
21(1)
49-58
56
Wenning G K, Litvan I, Jankovic J et al..
Natural history and survival of 14 patients with corticobasal degeneration confirmed
at postmortem examination.
J Neurol Neurosurg Psychiatry.
1998;
64(2)
184-189
57
Dickson D W.
Neuropathologic differentiation of progressive supranuclear palsy and corticobasal
degeneration.
J Neurol.
1999;
246(Suppl 2)
II6-II15
58
Wetter T C, Brunner H, Collado-Seidel V, Trenkwalder C, Winkelmann J.
Sleep and periodic limb movements in corticobasal degeneration.
Sleep Med.
2002;
3(1)
33-36
59
Iriarte J, Alegre M, Arbizu J, de Castro P.
Unilateral periodic limb movements during sleep in corticobasal degeneration.
Mov Disord.
2001;
16(6)
1180-1183
60 Caselli R J, Boeve B F.
The degenerative dementia . In: Goetz CG Textbook of Clinical Neurology. Philadelphia; Saunders/Elsevier 2007:
699-733
61
Liu W, Miller B L, Kramer J H et al..
Behavioral disorders in the frontal and temporal variants of frontotemporal dementia.
Neurology.
2004;
62(5)
742-748
62
Partinen M.
Sleep disorder related to Parkinson's disease.
J Neurol.
1997;
244(4, Suppl 1)
S3-S6
63
Kumar S, Bhatia M, Behari M.
Sleep disorders in Parkinson's disease.
Mov Disord.
2002;
17(4)
775-781
64
Lees A J, Blackburn N A, Campbell V L.
The nighttime problems of Parkinson's disease.
Clin Neuropharmacol.
1988;
11(6)
512-519
65
Factor S A, McAlarney T, Sanchez-Ramos J R, Weiner W J.
Sleep disorders and sleep effect in Parkinson's disease.
Mov Disord.
1990;
5(4)
280-285
66
Trenkwalder C.
Sleep dysfunction in Parkinson's disease.
Clin Neurosci.
1998;
5(2)
107-114
67
Karlsen K H, Larsen J P, Tandberg E, Maeland J G.
Influence of clinical and demographic variables on quality of life in patients with
Parkinson's disease.
J Neurol Neurosurg Psychiatry.
1999;
66(4)
431-435
68
Schenck C H, Bundlie S R, Ettinger M G, Mahowald M W.
Chronic behavioral disorders of human REM sleep: a new category of parasomnia.
Sleep.
1986;
9(2)
293-308
69
Schenck C H, Bundlie S R, Mahowald M W.
Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed
with idiopathic rapid eye movement sleep behaviour disorder.
Neurology.
1996;
46(2)
388-393
70
Frucht S, Rogers J D, Greene P E, Gordon M F, Fahn S.
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and
ropinirole.
Neurology.
1999;
52(9)
1908-1910
71
Comella C L, Morrissey M, Janko K.
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study
using actigraphy.
Neurology.
2005;
64(8)
1450-1451
72
Arnulf I.
Sleep and wakefulness disturbances in Parkinson's disease.
J Neural Transm Suppl.
2006;
(70)
357-360
73
Stack E L, Ashburn A M.
Impaired bed mobility and disordered sleep in Parkinson's disease.
Mov Disord.
2006;
21(9)
1340-1342
74
Borek L L, Kohn R, Friedman J H.
Mood and sleep in Parkinson's disease.
J Clin Psychiatry.
2006;
67(6)
958-963
75
Verbaan D, van Rooden S M, Visser M, Marinus J, van Hilten J J.
Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
Mov Disord.
2007;
23(1)
35-41
76
Currie L J, Bennett Jr J P, Harrison M B, Trugman J M, Wooten G F.
Clinical correlates of sleep benefit in Parkinson's disease.
Neurology.
1997;
48(4)
1115-1117
77
Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R.
Sleep benefit in Parkinson's disease.
Mov Disord.
1997;
12(4)
506-508
78
Högl B E, Gómez-Arévalo G, García S et al..
A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's
disease.
Neurology.
1998;
50(5)
1332-1339
79
Poceta J S, Parsons L, Engelland S, Kripke D F.
Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and
Parkinson's disease.
Sleep Med.
2009;
10(1)
129-133
80
Yamamura Y, Hattori N, Matsumine H, Kuzuhara S, Mizuno Y.
Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic
characteristics and molecular genetic identification.
Brain Dev.
2000;
22(Suppl 1)
S87-S91
81
Valente E M, Brancati F, Ferraris A European Consortium on Genetic Susceptibility
in Parkinson's Disease et al.
PARK6-linked parkinsonism occurs in several European families.
Ann Neurol.
2002;
51(1)
14-18
82
Scaglione C, Vignatelli L, Plazzi G Bologna, Genova, Parma and Pisa Universities group
for the study of REM Sleep Behavior Disorder in Parkinson's Disease et al.
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study.
Neurol Sci.
2005;
25(6)
316-321
83
Rye D B.
Contributions of the pedunculopontine region to normal and altered REM sleep.
Sleep.
1997;
20(9)
757-788
84
Rye D B.
The two faces of Eve: dopamine's modulation of wakefulness and sleep.
Neurology.
2004;
63(8, Suppl 3)
S2-S7
85
Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U.
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's
disease (preclinical and clinical stages).
J Neurol.
2002;
249(Suppl 3)
1-5
86
Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K.
Stages in the development of Parkinson's disease-related pathology.
Cell Tissue Res.
2004;
318(1)
121-134
87
Boeve B F, Silber M H, Saper C B et al..
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative
disease.
Brain.
2007;
130(Pt 11)
2770-2788
88
Stiasny-Kolster K, Doerr Y, Möller J C et al..
Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction
as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter
FP-CIT-SPECT.
Brain.
2005;
128(Pt 1)
126-137
89
Fantini M L, Postuma R B, Montplaisir J, Ferini-Strambi L.
Olfactory deficit in idiopathic rapid eye movements sleep behavior disorder.
Brain Res Bull.
2006;
70(4-6)
386-390
90
Gagnon J F, Postuma R B, Mazza S, Doyon J, Montplaisir J.
Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases.
Lancet Neurol.
2006;
5(5)
424-432
91
Postuma R B, Lang A E, Massicotte-Marquez J, Montplaisir J.
Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.
Neurology.
2006;
66(6)
845-851
92
Mazza S, Soucy J P, Gravel P et al..
Assessing whole brain perfusion changes in patients with REM sleep behavior disorder.
Neurology.
2006;
67(9)
1618-1622
93
Miyamoto T, Miyamoto M, Inoue Y, Usui Y, Suzuki K, Hirata K.
Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.
Neurology.
2006;
67(12)
2236-2238
94
Kumru H, Santamaria J, Tolosa E, Iranzo A.
Relation between subtype of Parkinson's disease and REM sleep behavior disorder.
Sleep Med.
2007;
8(7-8)
779-783
95
Tuin I, Voss U, Kessler K et al..
Sleep quality in a family with hereditary parkinsonism (PARK6).
Sleep Med.
2008;
9(6)
684-688
96
Benbir G, Ozekmekçi S, Cinar M, Beskardes F, Apaydin H, Erginöz E.
Features associated with the development of hallucinations in Parkinson's disease.
Acta Neurol Scand.
2006;
114(4)
239-243
97
Onofrj M, Bonanni L, Albani G, Mauro A, Bulla D, Thomas A.
Visual hallucinations in Parkinson's disease: clues to separate origins.
J Neurol Sci.
2006;
248(1-2)
143-150
98
Vendette M, Gagnon J F, Décary A et al..
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without
dementia.
Neurology.
2007;
69(19)
1843-1849
99
De Cock V C, Vidailhet M, Leu S et al..
Restoration of normal motor control in Parkinson's disease during REM sleep.
Brain.
2007;
130(Pt 2)
450-456
100
Braga-Neto P, da Silva-Júnior F P, Sueli Monte F, de Bruin P F, de Bruin V M.
Snoring and excessive daytime sleepiness in Parkinson's disease.
J Neurol Sci.
2004;
217(1)
41-45
101
Tandberg E, Larsen J P, Karlsen K.
Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based
study.
Mov Disord.
1999;
14(6)
922-927
102
Ondo W G, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J.
Daytime sleepiness and other sleep disorders in Parkinson's disease.
Neurology.
2001;
57(8)
1392-1396
103
Pal S, Bhattacharya K F, Agapito C, Chaudhuri K R.
A study of excessive daytime sleepiness and its clinical significance in three groups
of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono
and combination therapy.
J Neural Transm.
2001;
108(1)
71-77
104
Tracik F, Ebersbach G.
Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings.
Mov Disord.
2001;
16(3)
500-506
105
Arnulf I.
Excessive daytime sleepiness in parkinsonism.
Sleep Med Rev.
2005;
9(3)
185-200
106
Meindorfner C, Körner Y, Möller J C, Stiasny-Kolster K, Oertel W H, Krüger H P.
Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at
the wheel.
Mov Disord.
2005;
20(7)
832-842
107
Möller J C, Rethfeldt M, Körner Y et al..
Daytime sleep latency in medication-matched Parkinsonian patients with and without
sudden onset of sleep.
Mov Disord.
2005;
20(12)
1620-1622
108
Rissling I, Körner Y, Geller F, Stiasny-Kolster K, Oertel W H, Möller J C.
Preprohypocretin polymorphisms in Parkinson disease patients reporting “sleep attacks”.
Sleep.
2005;
28(7)
871-875
109
Rissling I, Geller F, Bandmann O et al..
Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting “sleep
attacks”.
Mov Disord.
2004;
19(11)
1279-1284
110
Rye D B, Johnston L H, Watts R L, Bliwise D L.
Juvenile Parkinson's disease with REM sleep behavior disorder, sleepiness, and daytime
REM onset.
Neurology.
1999;
53(8)
1868-1870
111
Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti C L.
Parkinsonism with excessive daytime sleepiness—a narcolepsy-like disorder?.
J Neurol.
2005;
252(2)
139-145
112
Thannickal T C, Lai Y Y, Siegel J M.
Hypocretin (orexin) cell loss in Parkinson's disease.
Brain.
2007;
130(Pt 6)
1586-1595
113
Gjerstad M D, Wentzel-Larsen T, Aarsland D, Larsen J P.
Insomnia in Parkinson's disease: frequency and progression over time.
J Neurol Neurosurg Psychiatry.
2007;
78(5)
476-479
114
Askenasy J J.
Sleep in Parkinson's disease.
Acta Neurol Scand.
1993;
87(3)
167-170
115 Chokroverty S.
Sleep in neurodegenerative diseases . In: Culebras A Sleep Disorders and Neurological Disease. New York; Marcel Dekker
Inc 2000: 217
116 Hening W A, Allen R, Walters A S, Chokroverty S.
Motor functions and dysfunctions of sleep . In: Chokroverty S Sleep Disorders Medicine: Basic Science, Technical Considerations
and Clinical Aspects. Philadelphia; Saunders/Elsevier 2009: 397-435
117
Vas C J, Parsonage M, Lord O C.
Parkinsonism associated with laryngeal spasm.
J Neurol Neurosurg Psychiatry.
1965;
28(5)
401-403
118
Corbin D O, Williams A C.
Stridor during dystonic phases of Parkinson's disease.
J Neurol Neurosurg Psychiatry.
1987;
50(6)
821-822
119
Vincken W G, Gauthier S G, Dollfuss R E, Hanson R E, Darauay C M, Cosio M G.
Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow
limitation.
N Engl J Med.
1984;
311(7)
438-442
120 Efthimiou J, Ellis S J, Hardie R J, Stern G M.
Sleep apnea in idiopathic and postencephalitic parkinsonism . In: Yahr MD, Bergmann KJ Parkinson's Disease (Advances in Neurology 45). New York;
Raven Press 1986: 275-276
121
Ondo W G, Vuong K D, Jankovic J.
Exploring the relationship between Parkinson disease and restless legs syndrome.
Arch Neurol.
2002;
59(3)
421-424
122
Garcia-Borreguero D, Odin P, Serrano C.
Restless legs syndrome and PD: a review of the evidence for a possible association.
Neurology.
2003;
61(6, Suppl 3)
S49-S55
123
Krishnan P R, Bhatia M, Behari M.
Restless legs syndrome in Parkinson's disease: a case-controlled study.
Mov Disord.
2003;
18(2)
181-185
124
Adel S, Djarmati A, Kabakci K et al..
Co-occurrence of restless legs syndrome and Parkin mutations in two families.
Mov Disord.
2006;
21(2)
258-263
125
Poewe W, Högl B.
Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease.
Neurology.
2004;
63(8, Suppl 3)
S12-S16
126
Allen R P, Earley C J.
Augmentation of the restless legs syndrome with carbidopa/levodopa.
Sleep.
1996;
19(3)
205-213
127
Kedia S, Moro E, Tagliati M, Lang A E, Kumar R.
Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease.
Neurology.
2004;
63(12)
2410-2412
128
Wetter T C, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C.
Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease
and multiple system atrophy.
Sleep.
2000;
23(3)
361-367
129
Happe S, Pirker W, Klösch G, Sauter C, Zeitlhofer J.
Periodic leg movements in patients with Parkinson's disease are associated with reduced
striatal dopamine transporter binding.
J Neurol.
2003;
250(1)
83-86
130
Wetter T C, Brunner H, Högl B, Yassouridis A, Trenkwalder C, Friess E.
Increased alpha activity in REM sleep in de novo patients with Parkinson's disease.
Mov Disord.
2001;
16(5)
928-933
131
Happe S, Schrödl B, Faltl M, Müller C, Auff E, Zeitlhofer J.
Sleep disorders and depression in patients with Parkinson's disease.
Acta Neurol Scand.
2001;
104(5)
275-280
132
Purdy A, Hahn A, Barnett H J et al..
Familial fatal Parkinsonism with alveolar hypoventilation and mental depression.
Ann Neurol.
1979;
6(6)
523-531
133
Mouret J.
Differences in sleep in patients with Parkinson's disease.
Electroencephalogr Clin Neurophysiol.
1975;
38(6)
653-657
134
Weisman D, McKeith I.
Dementia with Lewy bodies.
Semin Neurol.
2007;
27(1)
42-47
135
McKeith I G, Dickson D W, Lowe J Consortium on DLB et al.
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Neurology.
2005;
65(12)
1863-1872
136
Ferman T J, Boeve B F, Smith G E et al..
Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder
without parkinsonism or hallucinations.
J Int Neuropsychol Soc.
2002;
8(7)
907-914
137
Boeve B F, Silber M H, Ferman T J.
REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies.
J Geriatr Psychiatry Neurol.
2004;
17(3)
146-157
138
Boeve B F, Silber M H, Ferman T J et al..
REM sleep behavior disorder and degenerative dementia: an association likely reflecting
Lewy body disease.
Neurology.
1998;
51(2)
363-370
139
Boeve B F, Silber M H, Ferman T J, Lucas J A, Parisi J E.
Association of REM sleep behavior disorder and neurodegenerative disease may reflect
an underlying synucleinopathy.
Mov Disord.
2001;
16(4)
622-630
140
Olson E J, Boeve B F, Silber M H.
Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory
findings in 93 cases.
Brain.
2000;
123(Pt 2)
331-339
141
Boeve B F, Dickson D W, Olson E J et al..
Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant
Lewy body disease.
Sleep Med.
2007;
8(1)
60-64
142
Uchiyama M, Isse K, Tanaka K et al..
Incidental Lewy body disease in a patient with REM sleep behavior disorder.
Neurology.
1995;
45(4)
709-712
143
Harper D G, Stopa E G, McKee A C, Satlin A, Fish D, Volicer L.
Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease.
Neurobiol Aging.
2004;
25(6)
771-781
144
Baumann C R, Dauvilliers Y, Mignot E, Bassetti C L.
Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated
with excessive daytime sleepiness.
Eur Neurol.
2004;
52(2)
73-76
145
Gilman S, Low P, Quinn N et al..
[Consensus on the diagnosis of multi-system atrophy].
Neurologia.
1999;
14(9)
425-428
146
Gilman S, Wenning G K, Low P A et al..
Second consensus statement on the diagnosis of multiple system atrophy.
Neurology.
2008;
71(9)
670-676
147
Plazzi G, Corsini R, Provini F et al..
REM sleep behavior disorders in multiple system atrophy.
Neurology.
1997;
48(4)
1094-1097
148
Iranzo A, Molinuevo J L, Santamaría J et al..
Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative
disorder: a descriptive study.
Lancet Neurol.
2006;
5(7)
572-577
149
Iranzo A, Santamaría J, Rye D B et al..
Characteristics of idiopathic REM sleep behavior disorder and that associated with
MSA and PD.
Neurology.
2005;
65(2)
247-252
150
Gilman S, Koeppe R A, Chervin R D et al..
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA.
Neurology.
2003;
61(1)
29-34
151
Benarroch E E.
Brainstem in multiple system atrophy: clinicopathological correlations.
Cell Mol Neurobiol.
2003;
23(4-5)
519-526
152
Plazzi G, Corsini R, Provini F et al..
REM sleep behavior disorders in multiple system atrophy.
Neurology.
1997;
48(4)
1094-1097
153
Bannister R, Gibson W, Michaels L, Oppenheimer D R.
Laryngeal abductor paralysis in multiple system atrophy. A report on three necropsied
cases, with observations on the laryngeal muscles and the nuclei ambigui.
Brain.
1981;
104(2)
351-368
154
Cunchillos J D, De Andrés I.
Participation of the cerebellum in the regulation of the sleep-wakefulness cycle.
Results in cerebellectomized cats.
Electroencephalogr Clin Neurophysiol.
1982;
53(5)
549-558
155
Kitamura J, Kubuki Y, Tsuruta K, Kurihara T, Matsukura S.
A new family with Joseph disease in Japan. Homovanillic acid, magnetic resonance,
and sleep apnea studies.
Arch Neurol.
1989;
46(4)
425-428
156
Chokroverty S, Sachdeo R, Masdeu J.
Autonomic dysfunction and sleep apnea in olivopontocerebellar degeneration.
Arch Neurol.
1984;
41(9)
926-931
157
Salazar-Grueso E F, Rosenberg R S, Roos R P.
Sleep apnea in olivopontocerebellar degeneration: treatment with trazodone.
Ann Neurol.
1988;
23(4)
399-401
158
Salva M A, Guilleminault C.
Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia.
Neurology.
1986;
36(4)
576-577
159
Abele M, Bürk K, Laccone F, Dichgans J, Klockgether T.
Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3.
J Neurol.
2001;
248(4)
311-314
160
Friedman J H.
Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar
ataxia type 3).
Mov Disord.
2002;
17(6)
1350-1353
161
Iranzo A, Muñoz E, Santamaria J, Vilaseca I, Milà M, Tolosa E.
REM sleep behavior disorder and vocal cord paralysis in Machado-Joseph disease.
Mov Disord.
2003;
18(10)
1179-1183
162
Boesch S M, Frauscher B, Brandauer E, Wenning G K, Högl B, Poewe W.
Disturbance of rapid eye movement sleep in spinocerebellar ataxia type 2.
Mov Disord.
2006;
21(10)
1751-1754
163
Tuin I, Voss U, Kang J S et al..
Stages of sleep pathology in spinocerebellar ataxia type 2 (SCA2).
Neurology.
2006;
67(11)
1966-1972
164
Boesch S M, Frauscher B, Brandauer E, Wenning G K, Poewe W, Högl B.
Restless legs syndrome and motor activity during sleep in spinocerebellar ataxia type
6.
Sleep Med.
2006;
7(6)
529-532
165
Howell M J, Mahowald M W, Gomez C M.
Evaluation of sleep and daytime somnolence in spinocerebellar ataxia type 6 (SCA6).
Neurology.
2006;
66(9)
1430-1431
166 Tassinari C A, Broughton R, Poire R et al..
Sur l'Evolution des Mouvements Anormaux au Cours du Sommeil . In: Fischgold H Le Sommeil de Nuit Normal et Pathologique. Paris; Masson 1965: 314
167
Askenasy J JM.
Sleep patterns in extrapyramidal disorders.
Int J Neurol.
1981;
15(1-2)
62-76
168
Spire J P, Bliwise D L, Noronha A BC, Roos R P.
Sleep profiles in Huntington disease.
Neurology.
1981;
31(2)
151
169
Fish D R, Sawyers D, Allen P J, Blackie J D, Lees A J, Marsden C D.
The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de
la Tourette syndrome, Huntington's disease, and torsion dystonia.
Arch Neurol.
1991;
48(2)
210-214
170
Iakhno N N.
[Disorders of nocturnal sleep in Huntington chorea].
Zh Nevropatol Psikhiatr Im S S Korsakova.
1985;
85(3)
340-346
171
Emser W, Brenner M, Stober T, Schimrigk K.
Changes in nocturnal sleep in Huntington's and Parkinson's disease.
J Neurol.
1988;
235(3)
177-179
172
Sishta S K, Troupe A, Marszalek K S, Kremer L M.
Huntington's chorea: an electroencephalographic and psychometric study.
Electroencephalogr Clin Neurophysiol.
1974;
36(4)
387-393
173
Puca F M, Genco S, Minervini M G et al..
[Sleep in chronic chorea patients after therapy with sodium valproate].
Boll Soc Ital Biol Sper.
1984;
60(5)
989-992
174
Wiegand M, Möller A A, Lauer C J et al..
Nocturnal sleep in Huntington's disease.
J Neurol.
1991;
238(4)
203-208
175
Hurelbrink C B, Lewis S J, Barker R A.
The use of the Actiwatch-Neurologica system to objectively assess the involuntary
movements and sleep-wake activity in patients with mild-moderate Huntington's disease.
J Neurol.
2005;
252(6)
642-647
176
Morton A J, Wood N I, Hastings M H, Hurelbrink C, Barker R A, Maywood E S.
Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease.
J Neurosci.
2005;
25(1)
157-163
177
Yamamoto T, Hirose G, Shimazaki K, Takado S, Kosoegawa H, Saeki M.
Movement disorders of familial neuroacanthocytosis syndrome.
Arch Neurol.
1982;
39(5)
298-301
178
Danek A, Jung H H, Metone M A et al..
Neuroacanthocytosis: new developments in a neglected group of dementing disorders.
J Neurol Sci.
2005;
229–230
171-186
179
Silvestri R, De Domenico P, Di Rosa A E, Bramanti P, Serra S, Di Perri R.
The effect of nocturnal physiological sleep on various movement disorders.
Mov Disord.
1990;
5(1)
8-14
180
Silvestri R, Raffaele M, De Domenico P et al..
Sleep features in Tourette's syndrome, neuroacanthocytosis and Huntington's chorea.
Neurophysiol Clin.
1995;
25(2)
66-77
181
Hernández Vara J, Fernández Cortijo J, Purroy García F, Miquel Rodríguez F.
[Restless legs syndrome and neuroacanthocytosis].
Med Clin (Barc).
2005;
124(18)
717-718
182
Jankel W R, Niedermeyer E, Graf M, Kalsher M J, Kalsher M J.
Case report: polysomnographic effects of thalamotomy for torsion dystonia.
Neurosurgery.
1984;
14(4)
495-498
183
Jankel W R, Allen R P, Niedermeyer E, Kalsher M J.
Polysomnographic findings in dystonia musculorum deformans.
Sleep.
1983;
6(3)
281-285
184
Jankel W R, Niedermeyer E, Graf M, Kalsher M J.
Polysomnography of torsion dystonia.
Arch Neurol.
1984;
41(10)
1081-1083
185
Wein A, Golubev V.
Polygraphic analysis of sleep in dystonia musculorum deformans.
Waking Sleeping.
1979;
3(1)
41-50
186
Segawa M, Hosaka A, Miyagawa F, Nomura Y, Imai H.
Hereditary progressive dystonia with marked diurnal fluctuation.
Adv Neurol.
1976;
14
215-233
187
Segawa M.
Hereditary progressive dystonia with marked diurnal fluctuation.
Brain Dev.
2000;
22(Suppl 1)
S65-S80
188
Ichinose H, Ohye T, Takahashi E et al..
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations
in the GTP cyclohydrolase I gene.
Nat Genet.
1994;
8(3)
236-242
189
Ichinose H, Ohye T, Matsuda Y et al..
Characterization of mouse and human GTP cyclohydrolase I genes. Mutations in patients
with GTP cyclohydrolase I deficiency.
J Biol Chem.
1995;
270(17)
10062-10071
190
Sawle G V, Leenders K L, Brooks D J et al..
Dopa-responsive dystonia: [18F]dopa positron emission tomography.
Ann Neurol.
1991;
30(1)
24-30
191 de Yebenes J G, Moskowitz C, Fahn S, Saint-Hilaire M H.
Long-term treatment with levodopa in a family with autosomal dominant torsion dystonia . In: Fahn S, Marsden CD, Calne DB Dystonia 2. New York; Raven Press 1988: 101
192
Atalaia A, De Carvalho M, Evangelista T, Pinto A.
Sleep characteristics of amyotrophic lateral sclerosis in patients with preserved
diaphragmatic function.
Amyotroph Lateral Scler.
2007;
8(2)
101-105
193 Chokroverty S.
Sleep, breathing and neuromuscular disorders . In: Montagna P, Chokroverty S Handbook of Clinical Neurology: Sleep Disorders. Amsterdam;
Elsevier 2009
194
Kimura K, Tachibana N, Kimura J, Shibasaki H.
Sleep-disordered breathing at an early stage of amyotrophic lateral sclerosis.
J Neurol Sci.
1999;
164(1)
37-43
195
Barthlen G M, Lange D J.
Unexpectedly severe sleep and respiratory pathology in patients with amyotrophic lateral
sclerosis.
Eur J Neurol.
2000;
7(3)
299-302
196
Takekawa H, Kubo J, Miyamoto T, Miyamoto M, Hirata K.
Amyotrophic lateral sclerosis associated with insomnia and the aggravation of sleep-disordered
breathing.
Psychiatry Clin Neurosci.
2001;
55(3)
263-264
197
Zweig R M, Jankel W R, Hedreen J C, Mayeux R, Price D L.
The pedunculopontine nucleus in Parkinson's disease.
Ann Neurol.
1989;
26(1)
41-46
198
Jellinger K A.
Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.
Mol Chem Neuropathol.
1991;
14(3)
153-197
199
Paulus W, Jellinger K.
The neuropathologic basis of different clinical subgroups of Parkinson's disease.
J Neuropathol Exp Neurol.
1991;
50(6)
743-755
200
Wenning G K, Tison F, Ben Shlomo Y, Daniel S E, Quinn N P.
Multiple system atrophy: a review of 203 pathologically proven cases.
Mov Disord.
1997;
12(2)
133-147
201
Papp M I, Lantos P L.
The distribution of oligodendroglial inclusions in multiple system atrophy and its
relevance to clinical symptomatology.
Brain.
1994;
117(Pt 2)
235-243
202
Gilman S, Chervin R D, Koeppe R A et al..
Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA.
Neurology.
2003;
61(1)
35-39
203
Hornykiewicz O, Kish S J, Becker L E, Farley I, Shannak K.
Brain neurotransmitters in dystonia musculorum deformans.
N Engl J Med.
1986;
315(6)
347-353
204
Craig D, Hart D J, Passmore A P.
Genetically increased risk of sleep disruption in Alzheimer's disease.
Sleep.
2006;
29(8)
1003-1007
205
Benarroch E E, Smithson I L, Low P A, Parisi J E.
Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple
systems atrophy with autonomic failure.
Ann Neurol.
1998;
43(2)
156-163
206
Benarroch E E, Schmeichel A M, Parisi J E.
Depletion of cholinergic neurons of the medullary arcuate nucleus in multiple system
atrophy.
Auton Neurosci.
2001;
87(2-3)
293-299
207
Benarroch E E, Schmeichel A M.
Depletion of corticotrophin-releasing factor neurons in the pontine micturition area
in multiple system atrophy.
Ann Neurol.
2001;
50(5)
640-645
208
Benarroch E E, Schmeichel A M, Parisi J E.
Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system
atrophy.
Neurology.
2002;
59(6)
944-946
209
Benarroch E E, Schmeichel A M, Low P A, Parisi J E.
Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system
atrophy.
Brain.
2003;
126(Pt 10)
2183-2190
210
Benarroch E E, Schmeichel A M, Low P A, Parisi J E.
Depletion of putative chemosensitive respiratory neurons in the ventral medullary
surface in multiple system atrophy.
Brain.
2007;
130(Pt 2)
469-475
211
Benarroch E E, Schmeichel A M, Low P A, Parisi J E.
Involvement of medullary serotonergic groups in multiple system atrophy.
Ann Neurol.
2004;
55(3)
418-422
212
Benarroch E E, Schmeichel A M, Sandroni P, Low P A, Parisi J E.
Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease.
Neurology.
2006;
66(3)
378-383
213
Benarroch E E, Schmeichel A M, Sandroni P, Low P A, Parisi J E.
Involvement of hypocretin neurons in multiple system atrophy.
Acta Neuropathol.
2007;
113(1)
75-80
214
Benarroch E E.
Brainstem respiratory chemosensitivity: new insights and clinical implications.
Neurology.
2007;
68(24)
2140-2143
215
Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof P R.
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.
Brain Res Brain Res Rev.
2000;
33(1)
95-130
216
Forman M S, Lee V M, Trojanowski J Q.
New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.
J Chem Neuroanat.
2000;
20(3-4)
225-244
217
Duyckaerts C, Verny M, Hauw J J.
[Recent neuropathology of parkinsonian syndromes].
Rev Neurol (Paris).
2003;
159(5 Pt 2)
S11-S18
218
Krüger R, Müller T, Riess O.
Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative
disorders.
J Neural Transm.
2000;
107(1)
31-40
219
Chung K K, Dawson V L, Dawson T M.
New insights into Parkinson's disease.
J Neurol.
2003;
250(Suppl 3)
III15-III24
220
Doherty M J, Bird T D, Leverenz J B.
Alpha-synuclein in motor neuron disease: an immunohistologic study.
Acta Neuropathol.
2004;
107(2)
169-175
221 Chokroverty S.
Polysomnography in movement disorders . In: Hallett M Handbook of Clinical Neurophysiology: Movement Disorders. Amsterdam;
Elsevier 2003: 139
222
Tracik F, Ebersbach G.
Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings.
Mov Disord.
2001;
16(3)
500-506
223
Hansotia P, Wall R, Berendes J.
Sleep disturbances and severity of Huntington's disease.
Neurology.
1985;
35(11)
1672-1674
224
Diederich N J.
Welcome to the club: Substantial sleep dysfunction also in Progressive Supranuclear
Palsy.
Sleep Med.
2009;
10(4)
401-402
225
Fish D R, Allen P J, Sawyers D, Marsden C D.
Sleep spindles in torsion dystonia.
Arch Neurol.
1990;
47(2)
216-218
226
Neil J F, Holzer B C, Spiker D G, Coble P A, Kupfer D J.
EEG sleep alterations in olivopontocerebellar degeneration.
Neurology.
1980;
30(6)
660-662
227
McCurry S M, Reynolds C F, Ancoli-Israel S, Teri L, Vitiello M V.
Treatment of sleep disturbance in Alzheimer's disease.
Sleep Med Rev.
2000;
4(6)
603-628
228
NCSDR Working Group .
Insomnia: assessment and management in primary care.
Sleep.
1999;
22(Suppl 2)
S402-S408
229
Drugs and insomnia: the use of medications to promote sleep.
Bol Asoc Med P R.
1986;
78(7)
306-310
230
National Institutes of Health Consensus Group .
National Institutes of Health Consensus Development Conference Statement: the treatment
of sleep disorders of older people March 26-28, 1990.
Sleep.
1991;
14(2)
169-177
231
McCurry S M, Ancoli-Israel S.
Sleep dysfunction in Alzheimer's disease and other dementias.
Curr Treat Options Neurol.
2003;
5(3)
261-272
232
Zhdanova I V, Wurtman R J, Regan M M, Taylor J A, Shi J P, Leclair O U.
Melatonin treatment for age-related insomnia.
J Clin Endocrinol Metab.
2001;
86(10)
4727-4730
233
Olde Rikkert M G, Rigaud A S.
Melatonin in elderly patients with insomnia. A systematic review.
Z Gerontol Geriatr.
2001;
34(6)
491-497
234
Singer C, Tractenberg R, Kaye J et al..
A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's
disease.
Sleep.
2003;
26
893-901
235
Bourke S C, Tomlinson M, Williams T L, Bullock R E, Shaw P J, Gibson G J.
Effects of non-invasive ventilation on survival and quality of life in patients with
amyotrophic lateral sclerosis: a randomised controlled trial.
Lancet Neurol.
2006;
5(2)
140-147
236
Zesiewicz T A, Cimino C R, Malek A R et al..
Driving safety in Parkinson's disease.
Neurology.
2002;
59(11, 11)
1787-1788
237
Boeve B F, Silber M H, Ferman T J.
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results
in 14 patients.
Sleep Med.
2003;
4(4)
281-284
238
Takeuchi N, Uchimura N, Hashizume Y et al..
Melatonin therapy for REM sleep behavior disorder.
Psychiatry Clin Neurosci.
2001;
55(3)
267-269
239
Fantini M L, Gagnon J F, Filipini D, Montplaisir J.
The effects of pramipexole in REM sleep behavior disorder.
Neurology.
2003;
61(10)
1418-1420
240
Ancoli-Israel S, Kripke D F, Klauber M R, Mason W J, Fell R, Kaplan O.
Periodic limb movements in sleep in community-dwelling elderly.
Sleep.
1991;
14(6)
496-500
241
Campbell S S, Kripke D F, Gillin J C, Hrubovcak J C.
Exposure to light in healthy elderly subjects and Alzheimer's patients.
Physiol Behav.
1988;
42(2)
141-144
242
Sumaya I C, Rienzi B M, Deegan II J F, Moss D E.
Bright light treatment decreases depression in institutionalized older adults: a placebo-controlled
crossover study.
J Gerontol A Biol Sci Med Sci.
2001;
56(6)
M356-M360
243
Fetveit A, Bjorvatn B.
Bright-light treatment reduces actigraphic-measured daytime sleep in nursing home
patients with dementia: a pilot study.
Am J Geriatr Psychiatry.
2005;
13(5)
420-423
244
Ancoli-Israel S, Gehrman P, Martin J L et al..
Increased light exposure consolidates sleep and strengthens circadian rhythms in severe
Alzheimer's disease patients.
Behav Sleep Med.
2003;
1(1)
22-36
245
Skjerve A, Holsten F, Aarsland D, Bjorvatn B, Nygaard H A, Johansen I M.
Improvement in behavioral symptoms and advance of activity acrophase after short-term
bright light treatment in severe dementia.
Psychiatry Clin Neurosci.
2004;
58(4)
343-347
246
Wu Y H, Swaab D F.
Disturbance and strategies for reactivation of the circadian rhythm system in aging
and Alzheimer's disease.
Sleep Med.
2007;
8(6)
623-636
247
Dowling G A, Burr R L, Van Someren E J et al..
Melatonin and bright-light treatment for rest-activity disruption in institutionalized
patients with Alzheimer's disease.
J Am Geriatr Soc.
2008;
56(2)
239-246
Sudhansu ChokrovertyM.D. F.R.C.P.
Neuroscience Institute at JFK Medical Center
65 James Street, Edison, NJ 08818
eMail: schok@att.net